Besides, treatment with high-metastatic HCC-derived exosomal miR-92a-3p facilitates the aggressiveness of HCC cells via PTEN inhibition and Akt/Snail signaling activation, promoting EMT (Yang et al., 2020). This evidence concerns the gene SNAI1 and hepatocellular carcinoma.